Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer

Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer

Head and neck cancer is the sixth leading cancer worldwide; head and neck squamous cell carcinoma (HNSCC) accounts for more than 90% of incident cases. In the US, cases of HNSCC associated with human papillomavirus (HPV) have been growing in proportion amongst a younger demographic with superior out...

Full description

Bibliographic Details
Main Authors: Tasia Bos, J. Alex Ratti, Hisashi Harada
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oral Health
Subjects:
head and neck squamous cell carcinoma
radiotherapy
resistance
chemotherapy
targeted therapy
oxidative stress
Online Access:https://www.frontiersin.org/articles/10.3389/froh.2021.676643/full

Internet

https://www.frontiersin.org/articles/10.3389/froh.2021.676643/full

Similar Items